PD-1 blockade upregulate TIM-3 expression as a compensatory regulation of immune check point receptors in HNSCC TIL

Documenti analoghi

• Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer
  di: Shayan, Gulidanna, et al.
  Pubblicazione: (2016)
• Image guided cryoablation of cancer with intra-tumoral injection of anti-CTLA-4 and PD-1 immune check-point inhibitors
  di: Rosenberg, Mark A, et al.
  Pubblicazione: (2015)
• Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration
  di: Oweida, Ayman, et al.
  Pubblicazione: (2018)
• Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4(+) T Cells
  di: Saleh, Reem, et al.
  Pubblicazione: (2019)
• Differential expression of PD-1 and Tim-3 marks activation versus exhaustion status of T cells in the tumor microenvironment
  di: Li, Jing, et al.
  Pubblicazione: (2014)